Uric acid symptoms can be confusing because high uric acid itself may not cause obvious problems at first. Uric acid is a waste product made when the body breaks down purines, which are found naturally in the body and in certain foods. Most uric acid leaves the body through urine, but when levels become too high, sharp urate crystals may form in joints or the urinary tract. This can lead to painful gout attacks, kidney stones, or other kidney-related concerns.

Recognizing uric acid symptoms can help people understand when joint pain or urinary problems may need medical evaluation. Sudden pain in the big toe, swollen joints, warmth, redness, stiffness, lower back pain, painful urination, or blood in the urine may all point to uric acid-related issues. However, not everyone with high uric acid develops symptoms, and symptoms can overlap with infections, arthritis, injury, or other kidney problems. This article explains seven uric acid symptoms that may signal gout or kidney problems and why testing may be needed.

7 key high uric acid symptoms

The seven key symptoms of high uric acid are severe joint pain, lingering joint discomfort, joint inflammation and redness, limited range of motion, tophi (lumps under the skin), kidney stone pain, and urinary changes. These signs are the body’s direct response to the accumulation and crystallization of excess uric acid in the blood.

To understand better, these symptoms can be grouped by the body system they affect—the joints, the skin, and the urinary system—each signaling a different stage or manifestation of hyperuricemia.

Articular Manifestations: Acute and Lingering Joint Distress

Elevated systemic levels of purine metabolites can lead to specific structural and chemical changes throughout the body. The most common uric acid symptoms manifest within the skeletal joints, where excess monosodium urate drops out of solution and forms sharp, needle-like crystals within the synovial fluid. This crystal precipitation triggers an intense immune response, as white blood cells identify the deposits as foreign threats and launch an inflammatory attack.

Sudden, Severe Joint Pain (Podagra)

The hallmark sign of this metabolic backup is an acute gout flare. This pain starts abruptly, frequently waking an individual from deep sleep, and peaks in intensity within 4 to 12 hours. The crushing or throbbing sensation most commonly targets the metatarsophalangeal joint at the base of the big toe—a clinical presentation known as podagra that accounts for over half of all initial flares. The ankles, knees, wrists, and elbows are also common targets for these painful attacks.

Residual Inflammation and Restricted Mobility

• Lingering Joint Discomfort: After the intense peak of an acute flare subsides, low-grade inflammation can cause localized soreness, tenderness, and aching that lasts from a few days to several weeks.

• Inflammation and Redness: The active immune response causes the joint to swell, turn warm to the touch, and look dark red or purple. The overlying skin often stretches tight and appears shiny, a presentation that can look similar to a bacterial joint infection. Over time, these repeated inflammatory cycles restrict the joint’s normal range of motion, making regular movement difficult.

Dermal Complications: Chronic Tophaceous Formations

When metabolic clearance remains poor for several years, the continuous accumulation of urate shifts the disease from a cyclical joint issue to a chronic structural condition. This stage is marked by distinct skin changes that signal a heavy, uncontrolled crystal burden throughout the body.

To manage the unresolvable crystal deposits, the immune system walls off the sharp clusters inside granulomas—capsules made of inflammatory cells. These dense, concentrated structures are called tophi. They appear beneath the skin as firm, painless, yellowish-white nodules.

Because temperature drops encourage urate to crystallize, tophi typically form in cooler areas of the body, such as the fingers, hands, elbows, Achilles tendons, and the outer rim of the ear cartilage.

While tophi are generally not painful unless they press on a nearby nerve, they are far from harmless. Over time, these chalky deposits erode the surrounding bone and cartilage, causing permanent joint deformities and chronic arthritis.

If the overlying skin stretches too far and breaks down, the nodule can leak a white, pasty material made of urate crystals. This creates an open sore that is highly vulnerable to secondary bacterial infections.

Renal and Urinary Complications: Nephrolithiasis

Beyond damaging joints and soft tissues, a high concentration of purine waste products can heavily impact the renal system. This internal accumulation causes distinct urinary uric acid symptoms that match the development of solid stones within the kidneys and ureters.

[Acidic Urine + High Urate Concentrates] ──► Crystal Precipitation ──► Kidney Stone Formation

Renal Colic and Hematuria

The most severe symptom of this renal complication is renal colic—an intense, cramping pain that comes in waves as a stone moves through the narrow urinary tract. This pain starts in the flank area just below the ribs and radiates downward into the lower abdomen, groin, and genitals.

As the sharp edges of the stone scrape against the sensitive lining of the ureter, it causes bleeding, turning the urine pink, red, or smoky brown.

Understanding the Lithogenic Environment

When exploring what causes uric acid kidney stones, the primary driver is a combination of highly acidic urine and elevated urate concentrations. When urine pH drops consistently below 5.5, uric acid becomes far less soluble.

This acidic environment is a key factor in what causes uric acid kidney stones, as it forces dissolved urate to rapidly crystallize into solid, sharp-edged stones that the kidneys cannot easily flush out. Chronic dehydration or a diet heavy in animal proteins further concentrates these minerals, accelerating the stone-building process.

                     [Renal Pathological Matrix]
                                  │
     ┌────────────────────────────┴────────────────────────────┐
     ▼                                                         ▼
[Mechanical Blockage Signs]                              [Secondary UTI Signs]
 ├── Intense wave-like flank pain                         ├── Cloudy, dark urine output
 ├── Radiation to lower abdomen/groin                      ├── Strong, foul-smelling odor
 └── Traumatic hematoma (blood in urine)                  └── Persistent dysuria (burning urge)

Obstruction and Secondary Infections

A large stone can partially or completely block the flow of urine, creating a stagnant pool where bacteria can thrive. This stasis often leads to a secondary urinary tract infection.

Patients experiencing this complication will notice their urine looks cloudy or has a strong, foul odor. This is typically paired with systemic warning signs like a persistent, urgent need to urinate, a burning sensation during urination, and shaking chills or fevers.

How do high uric acid symptoms signal gout or kidney problems?

High uric acid symptoms directly signal gout or kidney problems because these conditions are the pathological outcomes of uric acid crystallizing in specific body tissues—the joints for gout and the renal system for kidney disease. The symptoms are not abstract warnings but are the physical and painful manifestations of this crystallization process causing inflammation, blockages, and tissue damage.

To understand better, the link between uric acid and these two conditions is rooted in the chemical properties of uric acid and the body’s reaction to its solid, crystalline form.

Pathological Transition: Hyperuricemia to Gouty Arthritis

The transition from a high concentration of purine waste in the blood (hyperuricemia) to an active case of gouty arthritis is a direct, causal chemical process. It begins when serum urate levels cross the physiological saturation threshold of approximately 6.8 mg/dL. Beyond this limit, the blood can no longer hold the compound in a dissolved state. The excess waste precipitates out of solution, turning into sharp, microscopic, needle-shaped monosodium urate (MSU) crystals that settle inside the synovial fluid of the joints.

[Serum Urate > 6.8 mg/dL] ──► MSU Crystal Precipitation ──► Joint Deposition ──► Macrophage Activation ──► IL-1β Cascade

This crystallization process favors cooler, peripheral areas of the body, which explains why the base of the big toe is the most common site for an attack. While these microcrystals can sit silently in the joint capsule for a time, minor trauma, dehydration, or rapid changes in blood chemistry can shift their position and trigger an acute flare:

• Immune Recognition: Phagocytic immune cells, such as macrophages and neutrophils, detect the sharp MSU crystals and treat them as dangerous foreign invaders.

• Phagocytosis and Rupture: As these immune cells swallow the rigid crystals, their internal structures puncture and rupture, releasing a flood of pro-inflammatory proteins called cytokines, specifically interleukin-1 beta ($IL\text{-}1\beta$).

• Inflammatory Cascade: This cytokine release triggers a major inflammatory response. Local blood vessels dilate and become porous, rushing fluid and white blood cells into the joint space. This sudden influx causes the severe swelling, heat, redness, and intense nerve pain that define an acute gout attack.

Renal Mechanisms: Urate Nephrolithiasis vs. Urate Nephropathy

The link between elevated purine waste and kidney damage moves along two distinct biological paths. While both conditions stem from urate crystals forming within the urinary tract, they impact the renal system in different ways, leading to both sudden blockages and long-term tissue decline.

                                [Renal Pathological Pathways]
                                              │
     ┌────────────────────────────────────────┴────────────────────────────────────────┐
     ▼                                                                                 ▼
[Urate Nephrolithiasis (Acute)]                                        [Urate Nephropathy (Chronic)]
 ├── Crystals form inside collecting ducts                              ├── Crystals settle directly in tissue tubules
 ├── Aggregates grow into solid stones                                  ├── Triggers persistent interstitial inflammation
 └── Triggers mechanical blockages & severe colic                       └── Causes progressive scarring & nephron loss

Urate Nephrolithiasis (Acute Stone Formation)

This path represents the acute phase of renal complications. When urine becomes highly concentrated and maintains an acidic pH below 5.5, the environment forces dissolved uric acid to rapidly form solid crystals. These crystals clump together within the kidney’s collecting ducts, eventually growing into solid stones.

If a stone slips down into the narrow ureter, it causes a physical blockage known as obstructive uropathy. This obstruction stops the flow of urine, backing up fluid and increasing pressure inside the kidney. This sudden pressure build-up causes intense, wave-like flank pain (renal colic), increases the risk of infection, and can cause an acute kidney injury if the blockage is not cleared quickly.

Urate Nephropathy (Chronic Structural Damage)

This path is a slower, more hidden form of kidney damage that takes place directly within the functional tissue of the organ. Instead of collecting in the open urinary channels, urate crystals lodge directly inside the kidney’s delicate tubules and interstitial tissue.

This deep tissue deposition triggers a persistent, low-grade inflammatory response. Over several years, this chronic inflammation leads to interstitial fibrosis—the replacement of healthy tissue with dense scar tissue—and gradually destroys the nephrons, which are the kidney’s basic filtering units.

As the number of functional nephrons drops, the kidney loses its ability to filter waste from the blood, regulate blood pressure, and balance electrolytes, steadily leading toward chronic kidney disease (CKD).

 Structural Comparison of Systemic Impacts

The main causes of high uric acid

The main causes of high uric acid (hyperuricemia) are the body either producing too much uric acid from the breakdown of purines or, more commonly, the kidneys failing to excrete enough uric acid in the urine. This imbalance can be driven by a combination of dietary habits, genetic predispositions, underlying medical conditions, and certain medications.

To begin, understanding these root causes is essential for developing an effective strategy to manage uric acid levels and prevent the onset of symptoms related to gout and kidney disease.

Dietary Substrates of Hyperuricemia

The accumulation of systemic purine waste is heavily driven by dietary inputs. When a person regularly consumes foods and beverages that are high in purines, the body’s metabolic pathways break these compounds down into uric acid as a final waste product. If this dietary intake is consistently high, it can overwhelm the body’s natural clearance systems, causing the compound to build up in the bloodstream and trigger noticeable uric acid symptoms.

[High-Purine Intake / Fructose] ──► Accelerated Hepatic Metabolism ──► Excess Uric Acid Production

Several major dietary categories can significantly increase this metabolic load:

High-Purine Organ and Red Meats: Standard red meats—including beef, lamb, and pork—contain concentrated amounts of purines. Organ meats, such as liver, kidneys, sweetbreads, and tripe, have even higher concentrations. Regularly eating these meats heavily increases the raw materials the body turns into uric acid.

Purine-Dense Seafood: While many fish offer excellent health benefits, certain types are loaded with purines and can worsen hyperuricemia. The most problematic options include small, oily fish like anchovies, sardines, and herring, alongside shellfish such as mussels and scallops.

Alcoholic Beverages: Alcohol raises purine waste through two distinct mechanisms. First, certain drinks like beer are naturally rich in purines derived from brewer’s yeast. Second, all forms of alcohol—including wine and spirits—slow down how well the kidneys filter waste. When the liver processes alcohol, it creates lactate. This lactate competes with uric acid for exit space inside the kidney’s tubules, forcing the kidneys to hold onto more uric acid and recirculate it through the blood.

High-Fructose Corn Syrup (HFCS): Foods and sodas sweetened with high-fructose corn syrup are a major, often overlooked driver of elevated purine waste. When the liver processes fructose, it accelerates the breakdown of adenosine triphosphate (ATP). This rapid chemical breakdown releases a surge of purines, which the body quickly turns into uric acid.

Metabolic and Pathological Drivers

Beyond what a person eats, several underlying medical conditions and lifestyle factors can disrupt how the body handles purine waste. These factors typically fall into two categories: they either cause the body to produce too much uric acid or, more commonly, they damage the kidneys’ ability to filter it out.

                         [Systemic Pathological Matrix]
                                       │
     ┌─────────────────────────────────┴─────────────────────────────────┐
     ▼                                                                   ▼
[Impaired Renal Excretion]                                  [Accelerated Waste Production]
 ├── Obesity & Adipocyte inflammation                        ├── Cellular breakdown from rapid weight loss
 ├── Vascular damage from hypertension                       ├── Genetic transport inefficiencies
 └── Tubular reabsorption via diuretics                      └── Concentrated serum via chronic dehydration

Chronic Medical Conditions

• Obesity and Metabolic Syndrome: Carrying excess body weight is one of the strongest risk factors for developing hyperuricemia. Fat cells release inflammatory signals that reduce the kidneys’ ability to clear urate. Additionally, obesity is closely tied to insulin resistance, a metabolic state that tells the kidneys to reabsorb uric acid rather than flush it out.

• Hypertension and Diabetes: Over time, high blood pressure and type 2 diabetes damage the delicate blood vessels inside the kidneys. This vascular wear and tear lowers the organs’ filtering efficiency, leaving more uric acid behind in the bloodstream.

• Pre-existing Kidney Disease: Because the kidneys filter out roughly two-thirds of the body’s uric acid, any stage of chronic kidney disease directly impairs this clearance. This creates a challenging cycle where high uric acid acts as both a cause and a consequence of declining kidney health.

Iatrogenic, Genetic, and Lifestyle Influences

High levels of purine waste can also be caused by genetic predispositions, specific prescription medications, or sudden shifts in hydration and body weight:

• Diuretic and Aspirin Medications: Several common medications can inadvertently raise uric acid levels. Thiazide diuretics used for blood pressure, as well as loop diuretics prescribed for fluid retention, cause the kidneys to reabsorb urate back into the blood. Similarly, taking low-dose aspirin daily for heart protection can lower the kidneys’ ability to excrete uric acid.

• Genetic Predispositions: A person’s baseline uric acid level is heavily influenced by their DNA. Some individuals inherit variations in their renal transport proteins that make their kidneys naturally less efficient at flushing out urate. For these individuals, hyperuricemia can develop even with a balanced diet and an active lifestyle.

• Dehydration and Concentrated Serum: When the body drops into a dehydrated state, the overall volume of blood decreases, making the concentration of uric acid look higher. At the same time, the kidneys prioritize conserving water, which temporarily slows down the removal of urate.

• Rapid Weight Loss and Crash Dieting: While managing obesity is important for long-term health, undergoing rapid weight loss or extreme crash diets can paradoxically trigger a sharp spike in uric acid. This spike happens because the rapid breakdown of fat and muscle tissue releases a massive wave of purines directly into the bloodstream all at once.

Mechanisms of Complication Formation

Understanding these varied causes helps clarify the broader relationship between purine waste and internal health complications. For example, when looking at what causes uric acid kidney stones, the issue is rarely just about eating high-purine foods. Instead, it is usually driven by a combination of factors.

[Dehydration + Metabolic Syndrome] ──► Concentrated, Acidic Urine (pH < 5.5) ──► Uric Acid Kidney Stones

When a person has metabolic syndrome, their urine naturally becomes more acidic. If that acidity is paired with dehydration or a high-purine diet, the kidneys become highly concentrated with urate.

This environment explains what causes uric acid kidney stones, as the low pH forces the dissolved waste to rapidly crystallize into solid stones. By addressing both dietary habits and underlying metabolic health, patients can effectively manage their uric acid levels and protect their joints and kidneys from long-term damage.

How are high uric acid levels diagnosed and managed?

High uric acid is diagnosed through blood tests, joint fluid analysis, and imaging, while management involves a dual approach of treating acute attacks with anti-inflammatories and lowering long-term urate levels with medication and lifestyle changes. Furthermore, understanding the nuances between diagnosis, target levels, and treatment strategies is crucial for effectively controlling the condition and preventing long-term complications such as joint damage and kidney disease.

Diagnostic Protocols for Hyperuricemia and Gout

Confirming elevated urate levels and identifying its associated complications requires a combination of laboratory tests and advanced imaging. While a simple blood test is the standard initial screening tool, a comprehensive medical evaluation often utilizes more definitive procedures to map out crystal buildup.

The Clinical Gold Standard: Arthrocentesis

The serum uric acid blood test measures the concentration of urate in the bloodstream, but it cannot definitively diagnose gout on its own because blood levels can fluctuate dynamically or even appear normal during an acute flare. To establish a definitive diagnosis, clinicians rely on joint fluid analysis, or arthrocentesis.

During this procedure, a sterile needle extracts a small sample of synovial fluid from the inflamed joint. A specialist examines this fluid under a polarized light microscope; finding distinct, needle-shaped monosodium urate (MSU) crystals provides unambiguous confirmation of gout.

Advanced Diagnostic Imaging

When joint fluid cannot be easily collected, advanced imaging protocols offer highly accurate alternatives to visualize crystal deposits:

• Musculoskeletal Ultrasound: This non-invasive method tracks urate crystal sheets settling on cartilage surfaces, revealing a specific diagnostic indicator known as the “double contour sign.” Ultrasound can also locate deeply buried tophi clusters before they can be felt during a physical exam.

• Dual-Energy Computed Tomography (DECT): As a highly specialized imaging path, DECT uses two different X-ray spectrums to distinguish between urate crystals and calcium deposits. This allows radiologists to precisely locate, color-code, and measure uric acid blockages throughout soft tissues and joints.

• Standard Radiography (X-rays): While standard X-rays cannot detect early-stage gout or soft tissue swelling, they are valuable for tracking chronic progression. They reveal distinct, “punched-out” bone erosions caused by long-term crystal buildup and can help evaluate the solid mineral blockages associated with what causes uric acid kidney stones.

Clinical Thresholds and Therapeutic Targets

Uric acid concentrations are measured in milligrams per deciliter (mg/dL). Managing the condition requires understanding the distinct boundaries between standard baseline physiology and the lower targets needed to actively dissolve disease deposits.

The general threshold for hyperuricemia sits at 6.8 mg/dL, which is the exact physical saturation point where urate drops out of solution at normal body temperature and pH. For individuals dealing with active uric acid symptoms, simply returning to a “normal” baseline is not enough.

The American College of Rheumatology recommends keeping serum urate levels consistently below 6.0 mg/dL to encourage existing crystals to dissolve back into the blood for elimination. In advanced cases with visible tophi or structural joint damage, physicians lower this target below 5.0 mg/dL to accelerate tissue healing.

Acute Flare Intervention vs. Long-Term Management

Successfully managing hyperuricemia requires a clear dual-treatment strategy. A common medical error is confusing short-term, reactive inflammation control with long-term, proactive waste-lowering therapies.

                      [Hyperuricemia Treatment Paradigm]
                                      │
     ┌────────────────────────────────┴────────────────────────────────┐
     ▼                                                                 ▼
[Acute Flare Response (Reactive)]                       [Urate-Lowering Therapy (Proactive)]
 ├── Goal: Suppress immediate inflammation               ├── Goal: Lower systemic urate production
 ├── NSAIDs (High-dose indomethacin)                     ├── Xanthine Oxidase Inhibitors (Allopurinol)
 ├── Colchicine (Halts crystal phagocytosis)             ├── Uricosurics (Boost renal probenecid output)
 └── Corticosteroids (Prednisone systemic block)         └── Uricase Infusions (Pegloticase conversion)

Acute Flare Response

Treating an active attack is entirely reactive and focuses on suppressing severe pain and swelling. These short-term medications must be started immediately but have no direct effect on circulating uric acid levels:

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): High-dose prescription NSAIDs like indomethacin or naproxen are used first to quickly calm joint pain and reduce local swelling.

• Colchicine: This specialized medication stops white blood cells from attacking urate crystals. It is highly effective but must be taken within the first 12 to 24 hours of an attack to change its course.

• Corticosteroids: Medications like prednisone, taken orally or injected directly into the joint space, provide powerful anti-inflammatory relief for patients who cannot safely take NSAIDs due to kidney issues.

Long-Term Management

Once joint inflammation subsides, the medical focus shifts to proactive preventative care using long-term Urate-Lowering Therapy (ULT). This strategy works to consistently lower the body’s total uric acid load using three main drug classes:

Xanthine oxidase inhibitors, such as Allopurinol or Febuxostat, are the most frequently prescribed long-term medications. They work by blocking the specific enzyme the liver uses to create uric acid from purines. For patients whose kidneys need assistance clearing this waste, uricosuric medications like Probenecid can be added to help the renal tubules flush out more urate through the urine.

In severe, treatment-resistant cases where thick tophi deform the joints, advanced uricase agents like Pegloticase are delivered via intravenous infusion. This medication converts stubborn, solid uric acid into allantoin—a highly soluble compound that the body can easily and safely excrete.

Managing Asymptomatic Hyperuricemia

It is common to have circulating uric acid levels well above 7.0 mg/dL without experiencing joint pain or structural kidney issues. This clinical state is called asymptomatic hyperuricemia.

Because many individuals carry high urate levels for decades without ever developing a painful gout flare, routine use of prescription ULT medications is generally not recommended for asymptomatic cases. This conservative approach protects patients from the unnecessary costs and potential side effects of lifelong medications that they may never actually need.

However, this clinical perspective is shifting for patients with significantly elevated urate concentrations. When blood levels cross 9.0 mg/dL, the risk of sudden crystal deposition rises sharply.

Chronically high urate is also tied to broader systemic conditions, including high blood pressure, cardiovascular disease, and chronic kidney decline. For most asymptomatic individuals, physicians focus on proactive lifestyle modifications.

Patients are advised to optimize their weight, stay well-hydrated to help dilute renal fluids, and reduce their intake of high-purine meats and high-fructose corn syrup. These adjustments help control metabolic waste and reduce the risk of developing joint pain or dealing with the painful blockages associated with what causes uric acid kidney stones.

Conclusion

Uric acid symptoms often become noticeable only after crystals affect the joints or urinary tract. Gout may cause sudden joint pain, swelling, redness, warmth, and limited movement, while uric acid kidney stones may cause severe back or side pain, blood in urine, nausea, vomiting, or painful urination. Since high uric acid can exist silently, blood and urine tests may be needed to understand what is happening. If symptoms are severe, recurrent, or linked with fever, vomiting, reduced urination, or intense pain, medical care should be sought promptly.

Read more: 8 Warning Signs of Vascular EDS Complications

Frequently Asked Questions

1. What are common uric acid symptoms?

Common uric acid symptoms may include sudden joint pain, swelling, redness, warmth, stiffness, and tenderness. These symptoms often happen during a gout attack and may affect the big toe, ankle, knee, wrist, or fingers. Uric acid stones may cause back pain, side pain, blood in urine, nausea, or painful urination. Some people with high uric acid have no symptoms until gout or kidney stones develop.

2. How does high uric acid cause gout?

High uric acid can lead to gout when urate crystals form in and around the joints. These crystals can trigger sudden inflammation, causing severe pain, swelling, warmth, and redness. A gout attack often begins quickly and may feel intense even with light touch. The big toe is a common location, but gout can affect many joints.

3. Can high uric acid affect the kidneys?

Yes, high uric acid can affect the kidneys by contributing to uric acid kidney stones. These stones can form when uric acid crystals build up in the urinary tract. Symptoms may include sharp back or side pain, blood in urine, nausea, vomiting, or pain while urinating. Recurrent kidney stones should be evaluated because treatment may help reduce future episodes.

4. Does high uric acid always cause symptoms?

No, high uric acid does not always cause symptoms. Many people have elevated uric acid levels without gout attacks or kidney stones. This is why high uric acid may only be found during blood testing for another reason. A healthcare provider can decide whether treatment or monitoring is needed based on symptoms, risk factors, and test results.

5. How are uric acid problems diagnosed?

Uric acid problems may be diagnosed with a blood uric acid test, urine testing, joint fluid analysis, imaging, or kidney stone analysis. A blood test can show whether uric acid levels are elevated, but it does not confirm gout by itself. Joint fluid testing can identify urate crystals during a gout attack. Imaging may be used when kidney stones or joint damage are suspected.

Sources

1. Hyperuricemia: High Uric Acid Level (Cleveland Clinic)
2. Uric Acid Test (MedlinePlus)
3. Uric Acid – Blood (MedlinePlus Medical Encyclopedia)
4. Gout – Symptoms and Causes (Mayo Clinic)
5. Gout – Diagnosis and Treatment (Mayo Clinic)
6. Uric Acid Stones: Causes, Symptoms & Treatment (Cleveland Clinic)
7. Definition & Facts for Kidney Stones (NIDDK)
8. Uric Acid Nephrolithiasis (StatPearls, NCBI Bookshelf)